Rocket


Overview
Financials
News + Filings





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


NUGENEREX IMMUNO-ONCOLOGY, INC. Create: Alert

All | News | Filings
Date FiledTypeDescription
11/01/2021 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
07/23/2021 8-K Other Events
06/14/2021 10-Q Quarterly Report for the period ended April 30, 2021
05/21/2021 DEFR14C Form DEFR14C - Revised information statement materials, definitive:
05/21/2021 DEF 14C Form DEF 14C - Other definitive information statements:
05/20/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/19/2021 PRE 14C Form PRE 14C - Other preliminary information statements:
05/19/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/27/2021 8-K Quarterly results
03/12/2021 10-Q Quarterly Report for the period ended January 31, 2021
02/10/2021 8-K Quarterly results
02/02/2021 8-K Quarterly results
01/08/2021 8-K Quarterly results
12/17/2020 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "The Extension Agreement signed December 15, 2020",
"The Letter requesting more time for payment signed December 14, 2020"
12/17/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "The Extension Agreement signed December 15, 2020"
12/15/2020 10-Q/A Quarterly Report for the period ended October 31, 2020 [amend]
12/15/2020 10-Q Quarterly Report for the period ended October 31, 2020
11/25/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "INDEMNITY",
"INDEMNITY"
11/19/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "The Ii-Key Innovative Flu Vaccine Development Agreement signed November 13, 2020",
"Generex signs Worldwide Licensing Deal with China Partners on the Development of an Ii-Key-H1 Swine Influenza Vaccine"
11/18/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "The Ii-Key Innovative Vaccine Development Agreement signed November 13, 2020",
"Generex Inks $50 Million Licensing Deal with China Partners on the Cooperative Development of the Ii-Key Vaccine Platform"
11/05/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Framework Agreement on Cooperative Development of Coronavirus Peptide Vaccine signed October 30, 2020",
"Generex Announces the Signing of a Framework Agreement with The China CDC, Beijing Guoxin Haixiang Equity Investment Partnership and Beijing Youfeng International Consulting Co., Ltd on the Cooperative Development of Ii-Key Vaccines"
10/29/2020 10-K Annual Report for the period ended July 31, 2020
10/14/2020 8-K Quarterly results
09/14/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
09/14/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
09/14/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/13/2020 10-12G/A Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
07/23/2020 10-12G/A Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
07/20/2020 8-K Quarterly results
06/23/2020 8-K Quarterly results
06/19/2020 10-Q Quarterly Report for the period ended April 30, 2020
06/17/2020 10-Q Quarterly Report for the period ended January 31, 2020
06/15/2020 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
06/12/2020 10-12G/A Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy